Quercetin prevents diastolic dysfunction induced by a high-cholesterol diet: role of oxidative stress and bioenergetics in hyperglycemic rats
Author
dc.contributor.author
Castillo, Rodrigo L.
Author
dc.contributor.author
Herrera Videla, Emilio
Author
dc.contributor.author
González Candia, Alejandro
Author
dc.contributor.author
Reyes Farías, Marjorie
Author
dc.contributor.author
Jara, Nicole de la
Author
dc.contributor.author
Peña, Juan Pedro
Author
dc.contributor.author
Carrasco Pozo, Catalina
Admission date
dc.date.accessioned
2018-07-31T15:38:39Z
Available date
dc.date.available
2018-07-31T15:38:39Z
Publication date
dc.date.issued
2018
Cita de ítem
dc.identifier.citation
Oxidative Medicine and Cellular Longevity Número de artículo: 7239123
es_ES
Identifier
dc.identifier.other
10.1155/2018/7239123
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/150487
Abstract
dc.description.abstract
Alterations in cardiac energy metabolism play a key role in the pathogenesis of diabetic cardiomyopathy. Hypercholesterolemia associated with bioenergetic impairment and oxidative stress has not been well characterized in the cardiac function under glycemic control deficiency conditions. This work aimed to determine the cardioprotective effects of quercetin (QUE) against the damage induced by a high-cholesterol (HC) diet in hyperglycemic rats, addressing intracellular antioxidant mechanisms and bioenergetics. Quercetin reduced HC-induced alterations in the lipid profile and glycemia in rats. In addition, QUE attenuated cardiac diastolic dysfunction (increased E:A ratio), prevented cardiac cholesterol accumulation, and reduced the increase in HC-induced myocyte density. Moreover, QUE reduced HC-induced oxidative stress by preventing the decrease in GSH/GSSG ratio, Nrf2 nuclear translocation, HO-1 expression, and antioxidant enzymatic activity. Quercetin also counteracted HC-induced bioenergetic impairment, preventing a reduction in ATP levels and alterations in PGC-1 alpha, UCP2, and PPAR. expression. In conclusion, the mechanisms that support the cardioprotective effect of QUE in rats with HC might be mediated by the upregulation of antioxidant mechanisms and improved bioenergetics on the heart. Targeting bioenergetics with QUE can be used as a pharmacological approach to modulate structural and functional changes of the heart under hypercholesterolemic and hyperglycemic conditions.